Japay, Brenda T.

HRN: 21-06-64  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/10/2022
CEFUROXIME 1.5GM (VIAL)
04/10/2022
04/17/2022
IV
1.5gm, Then 750mg
Q8H
OR Prophylaxis

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Non-compliant To Guidelines